Radcliffe Capital Management, L.P. - PDL BIOPHARMA INC ownership

Back to all holdings Add to watchlist

PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAF1.

Links
Filings
Quarter-by-quarter ownership
Radcliffe Capital Management, L.P. ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q4 2017$20,907,000
+5.9%
20,913,000
+6.1%
3.10%
+9.3%
Q3 2017$19,738,000
+70.5%
19,703,000
+69.9%
2.83%
+64.0%
Q2 2017$11,579,000–11,598,000–1.73%–
 Download
Other shareholders

There were no reported owners of PDL BIOPHARMA INC in Q1 2018.

NameSharesValueWeighting ↓
View complete list of PDL BIOPHARMA INC shareholders